A detailed history of Crossvault Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Crossvault Capital Management LLC holds 27,663 shares of LLY stock, worth $20.7 Million. This represents 3.53% of its overall portfolio holdings.

Number of Shares
27,663
Previous 29,488 6.19%
Holding current value
$20.7 Million
Previous $8.44 Million 6.22%
% of portfolio
3.53%
Previous 2.72%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$278.73 - $327.27 $508,682 - $597,267
-1,825 Reduced 6.19%
27,663 $8.97 Million
Q1 2022

May 05, 2022

BUY
$234.69 - $291.66 $98,569 - $122,497
420 Added 1.44%
29,488 $8.44 Million
Q4 2021

Feb 07, 2022

BUY
$224.85 - $279.04 $539,864 - $669,975
2,401 Added 9.0%
29,068 $8.03 Million
Q3 2021

Nov 09, 2021

SELL
$221.6 - $272.71 $368,964 - $454,062
-1,665 Reduced 5.88%
26,667 $6.16 Million
Q2 2021

Aug 12, 2021

BUY
$180.55 - $233.54 $748,379 - $968,023
4,145 Added 17.14%
28,332 $6.9 Million
Q1 2021

Apr 28, 2021

SELL
$164.32 - $212.72 $2,957 - $3,828
-18 Reduced 0.07%
24,187 $4.52 Million
Q4 2020

Feb 08, 2021

BUY
$130.46 - $172.63 $251,787 - $333,175
1,930 Added 8.66%
24,205 $4.09 Million
Q3 2020

Oct 21, 2020

BUY
$146.22 - $169.13 $358,239 - $414,368
2,450 Added 12.36%
22,275 $3.3 Million
Q2 2020

Aug 05, 2020

BUY
$136.42 - $164.18 $1.13 Million - $1.35 Million
8,250 Added 71.27%
19,825 $3.26 Million
Q3 2019

Oct 30, 2019

SELL
$106.79 - $116.16 $52,861 - $57,499
-495 Reduced 4.1%
11,575 $1.29 Million
Q1 2019

Apr 24, 2019

SELL
$111.31 - $131.02 $2,782 - $3,275
-25 Reduced 0.21%
12,070 $1.57 Million
Q4 2018

Jan 30, 2019

SELL
$105.9 - $118.64 $58,245 - $65,252
-550 Reduced 4.35%
12,095 $1.4 Million
Q4 2017

Jan 23, 2018

SELL
$81.94 - $87.89 $4,097 - $4,394
-50 Reduced 0.39%
12,645 $1.07 Million
Q3 2017

Oct 30, 2017

BUY
$77.07 - $85.54 $978,403 - $1.09 Million
12,695
12,695 $1.09 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Crossvault Capital Management LLC Portfolio

Follow Crossvault Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossvault Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crossvault Capital Management LLC with notifications on news.